Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| IRD | OPUS GENETICS INC | $43.07M | 45,483,823 | 1.17% | 98.83% | Net Buying | Net Selling | ||
| SGMO | SANGAMO THERAPEUTICS INC | $157.30M | 224,710,019 | 27.37% | 14.33% | Net Selling | Net Selling | ||
| BLUE | BLUEBIRD BIO INC | $34.27M | 9,790,070 | 18.67% | 81.33% | Net Selling | Net Selling | ||
| SABS | SAB BIOTHERAPEUTICS INC | $16.63M | 9,288,868 | 4.81% | 95.19% | ||||
| CALC | CALCIMEDICA INC | $26.96M | 13,481,917 | 14.43% | 85.57% | Net Buying | |||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $23.76M | 377,132,220 | 1.10% | 4.49% | ||||
| IBIO | IBIO INC | $12.77M | 16,519,281 | 7.03% | 92.97% | Net Buying | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $351.31M | 266,141,411 | 63.24% | 0.00% | ||||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $399.93M | 53,826,982 | 55.93% | 44.07% | Net Selling | Net Selling | ||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.85M | 11,454,512 | 11.12% | 0.00% | ||||
| ATXS | ASTRIA THERAPEUTICS INC | $238.72M | 56,434,219 | 80.96% | 19.04% | ||||
| VIGL | VIGIL NEUROSCIENCE INC | $112.95M | 46,671,534 | 41.59% | 58.41% | Net Buying | |||
| EVAX | EVAXION BIOTECH A | $2.09M | 70,130,556 | 1.15% | 0.00% | ||||
| OTLK | OUTLOOK THERAPEUTICS INC | $48.99M | 32,017,179 | 2.26% | 97.74% | Net Buying | |||
| RNXT | RENOVORX INC | $38.74M | 36,546,752 | 2.77% | 12.46% | Net Buying | Net Buying | ||
| VIR | VIR BIOTECHNOLOGY INC | $702.94M | 138,238,003 | 61.95% | 38.05% | Net Selling | Net Selling | ||
| LFWD | LIFEWARD LTD | $14.56M | 10,630,281 | 1.04% | 98.96% | Net Selling | |||
| GEVO | GEVO INC | $277.95M | 239,609,874 | 21.53% | 11.98% | Net Selling | Net Selling | ||
| AZUL | AZUL SA | $74.47M | 1,264,715,854 | 1.00% | 0.00% | ||||
| CTSO | CYTOSORBENTS CORP | $54.44M | 62,500,000 | 24.53% | 44.74% | Net Buying | Net Buying | ||
| GOSS | GOSSAMER BIO INC | $252.22M | 227,221,261 | 75.40% | 14.63% | Net Buying | |||
| IBRX | IMMUNITYBIO INC | $1.77B | 853,442,137 | 9.68% | 8.96% | Net Buying | Net Selling | ||
| IMAB | I-MAB | $71.76M | 187,452,495 | 6.36% | 0.00% | ||||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | $75.52M | 1,543,391,646 | 6.37% | 93.63% | Net Selling | |||
| CTNM | CONTINEUM THERAPEUTICS INC | $100.12M | 25,871,549 | 61.00% | 10.44% | Net Buying | |||
| TIL | INSTIL BIO INC | $86.34M | 6,525,887 | 6.44% | 93.56% | ||||
| CLSD | CLEARSIDE BIOMEDICAL INC | $66.27M | 77,143,872 | 12.24% | 35.53% | Net Buying | Net Buying | ||
| VERV | VERVE THERAPEUTICS INC | $375.61M | 88,795,768 | 63.38% | 36.62% | Net Buying | Net Selling | ||
| PYXS | PYXIS ONCOLOGY INC | $65.90M | 61,590,415 | 51.20% | 37.91% | Net Buying | |||
| ADCT | ADC THERAPEUTICS SA | $125.84M | 99,083,838 | 56.84% | 43.16% | Net Buying | Net Buying | ||
| TARA | PROTARA THERAPEUTICS INC | $125.01M | 38,581,863 | 48.52% | 51.48% | Net Selling | Net Selling | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $314.33M | 68,333,065 | 74.06% | 25.94% | Net Selling | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $753.09M | 107,737,919 | 59.56% | 40.44% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.